These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15323311)

  • 1. [Using miacalcic nasal spray 200 UI in the treatment of osteoporosis in women of 40-70 years of age during menopause according to data of the center "Osteoporosis" in Khaskovo city].
    Staĭkova N; Filipov P
    Akush Ginekol (Sofiia); 2004; 43 Suppl 1():10-4. PubMed ID: 15323311
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of intranasal salmon calcitonin treatment in postmenopausal osteoporosis].
    Kopaliani M
    Georgian Med News; 2005 Apr; (121):38-42. PubMed ID: 15908722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.
    Gennari C; Agnusdei D; Camporeale A
    Osteoporos Int; 1993; 3 Suppl 1():208-10. PubMed ID: 8461563
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcitonin.
    Silverman SL
    Am J Med Sci; 1997 Jan; 313(1):13-6. PubMed ID: 9001161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intra-nasal calcitonin for the prevention of postmenopausal osteoporosis].
    Meunier PJ
    Rev Med Univ Navarra; 1992; 37(4):200-4. PubMed ID: 1298037
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
    Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
    Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women.
    Downs RW; Bell NH; Ettinger MP; Walsh BW; Favus MJ; Mako B; Wang L; Smith ME; Gormley GJ; Melton ME
    J Clin Endocrinol Metab; 2000 May; 85(5):1783-8. PubMed ID: 10843152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early therapy of osteoporosis with (1-38) parathyroid hormone and calcitonin nasal spray].
    Hesch RD; Rittinghaus EF; Harms HM; Delling G
    Med Klin (Munich); 1989 Oct; 84(10):488-98. PubMed ID: 2685534
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
    Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
    J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of osteoporosis in women with breast cancer.
    Mincey BA; Moraghan TJ; Perez EA
    Mayo Clin Proc; 2000 Aug; 75(8):821-9. PubMed ID: 10943237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
    Tolino A; Romano L; Ronsini S; Riccio S; Montemagno U
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):358-60. PubMed ID: 8370634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
    Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
    Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate in the treatment of osteoporosis.
    Adami S
    Aging (Milano); 1998 Apr; 10(2):159-60. PubMed ID: 9666215
    [No Abstract]   [Full Text] [Related]  

  • 14. Salmon calcitonin nasal spray treatment for postmenopausal women after hip fracture with total hip arthroplasty.
    Peichl P; Marteau R; Griesmacher A; Kumpan W; Schedl R; Prosquil E; Fasol P; Bröll H
    J Bone Miner Metab; 2005; 23(3):243-52. PubMed ID: 15838628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of different doses of calcitonin on bone mineral density and fracture risk in postmenopausal osteoporosis.
    Hizmetli S; Elden H; Kaptanoglu E; Nacitarhan V; Kocagil S
    Int J Clin Pract; 1998 Oct; 52(7):453-5. PubMed ID: 10622084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of calcitonin tolerance after intramuscular or intranasal administration in treatment for postmenopausal osteoporosis].
    Horst-Sikorska W; Ruszkowska J; Kosowicz J
    Przegl Lek; 1996; 53(1):9-11. PubMed ID: 8711177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin and the treatment of osteoporosis.
    Schneyer CR
    Md Med J; 1991 Jun; 40(6):469-73. PubMed ID: 1861574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug treatment of osteoporosis (in the woman)].
    Ziegler R
    Ther Umsch; 1998 Nov; 55(11):696-701. PubMed ID: 9865146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of postmenopausal osteoporosis with low doses of calcitonin and a calcitonin-anabolic combination].
    Szücs J; Horváth C; Kollin E; Szathmári M; Holló I
    Orv Hetil; 1992 Jun; 133(23):1415-8. PubMed ID: 1603585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
    Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
    Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.